← Back to Search

Care Partner Assessment Tool for Dementia

N/A

Recruiting

Led By Beth Fields, PhD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 72 hours post-discharge

Awards & highlights

Study Summary

This trial looks at whether a care partner questionnaire can help people with dementia get better care when they leave the hospital. Care partners of hospitalized dementia patients take part in the trial for 14 days.

Who is the study for?

This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.Check my eligibility

What is being tested?

The study is testing the CHAT-AD, an assessment tool designed to improve post-hospital care for people with dementia. Care partners will use this questionnaire to help ensure better ongoing care once the patient returns home from the hospital.See study design

What are the potential side effects?

Since this trial involves using a questionnaire tool rather than medication, there are no direct medical side effects. However, participants may experience emotional or psychological stress while discussing sensitive topics about their caregiving experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 72 hours post-discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~72 hours post-discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Care partner satisfaction of care

Change in Preparedness for Caregiving

Secondary outcome measures

Change in care partner burden

Change in care partner depression

Feasibility measure: Implementation satisfaction

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Adjusted CHAT-ADExperimental Treatment1 Intervention

Using CHAT, participants will be asked questions about their needs to fully support and care for their loved one after the loved one is released from the hospital.

Group II: Standard of CareActive Control1 Intervention

Participants in this arm will only receive standard of care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,748 Total Patients Enrolled

21 Trials studying Dementia

10,871 Patients Enrolled for Dementia

University of Wisconsin, MadisonLead Sponsor

1,189 Previous Clinical Trials

3,169,418 Total Patients Enrolled

8 Trials studying Dementia

1,708 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,797 Total Patients Enrolled

268 Trials studying Dementia

23,627,478 Patients Enrolled for Dementia

Media Library

Adjusted CHAT-AD Clinical Trial Eligibility Overview. Trial Name: NCT05592366 — N/A

Dementia Research Study Groups: Standard of Care, Adjusted CHAT-AD

Dementia Clinical Trial 2023: Adjusted CHAT-AD Highlights & Side Effects. Trial Name: NCT05592366 — N/A

Adjusted CHAT-AD 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592366 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any possibility to enroll in this trial at present?

"Per the information on clinicaltrials.gov, patient recruitment for this trial is presently closed. The study was initially posted on November 1st 2022 and has since been updated most recently on November 21st 2022. However, a multitude of 766 other trials are actively seeking participants right now."

Answered by AI

What is the purpose of this investigation?

"This research project aims to measure care-partner satisfaction with treatment over a timespan from the onset of symptoms until seventy two hours post-discharge. Additionally, qualitative interviews will be held to investigate attrition rates and data analysis shall uncover emergent themes related thereto. Furthermore, investigators shall record time taken by patients to complete assessments and CHAT-AD tests as well as contentedness derived from Zarit Burden Interviews which assesses burden levels through responses on a five point scale."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dementia Care Partner Hospital Assessment Tool

2024. "Dementia Care Partner Hospital Assessment Tool". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05592366.

All > Dementia